You have a positioning angle that is not 'just another greens powder.' You have a target audience that reads ingredient panels. You need a cGMP factory that will run 1,000 units of a custom blend, hand you a COA you can publish, and not require a $50k retainer to get on the calendar. Here is the path.
// Honest read
You are not a first-time founder. You have run a brand. Maybe you sold one. The supplement category caught your eye because the unit economics work — DTC LTV at 12 months can hit 4-6x acquisition cost if the SKU performs. You have a thesis: 'sleep stack without melatonin,' 'creatine that does not bloat,' 'gut-brain stack for women in perimenopause.' You have read every Examine.com page on the actives. You have a brand name and a domain. What you do not have is a factory.
You looked at the public lists — Makers Nutrition, NutraScience Labs, Bactolac, Robinson Pharma, Vitaquest. Most of them have a 5,000-unit minimum and a 16-week lead time on a custom blend. The ones that quote 1,000-unit minimums are usually private-label only — you take their stock SKU and put your label on it. Which is fine for category #2 SKU but kills your positioning for the hero product.
The third layer is the formulator question. Most contract manufacturers have in-house formulators. Some lock you to their formulator. Some let you bring your own — independent supplement formulators run $5,000-$15,000 per formula and they are worth it because they will write a formula that is manufacturable at scale, not a formula that works at the bench and falls apart at the blender.
Supplements are not harder than beauty — they are just gated harder on the manufacturing side because of cGMP. Four steps.
Write the formula in active + dose format, with the rationale and source citation for each active. The factory will quote against this. Run the DSHEA screen on every claim that will appear on the label, the website, and the ad creative — structure-function claims are allowed with the FDA disclaimer; disease claims are not. Confirm none of your actives are on the FDA's prohibited list (ephedra, kava in some forms, certain peptide blends, certain SARMs-adjacent compounds). The screen narrows your shortlist and saves you a label reprint.
Three contract manufacturers. All three should be FDA-registered Food Facilities (free public registry at FDA.gov) and operating to 21 CFR 111 cGMP. NSF and NPA certification are bonuses — NSF specifically issues a public list of certified dietary supplement manufacturers. Quote all three against the same one-page brief. Get exclusivity in writing on the formula. Get batch-level COA scoped in. Get third-party assay verification scoped in for the first three batches.
Order a paid sample run — typically 100-500 units. The factory will hand you a COA from their in-house or contracted lab. Send a sample to an independent third-party lab (Eurofins, Alkemist, Covance) and run the same assay. The two COAs should match within 5%. If they do not match, that is your tell — either the factory's lab is sloppy, or the spec was not actually produced. Decide before you sign the production PO.
Sign the production PO. Confirm batch-level COA, lot code on every bottle and case, expiry date on every bottle, sealed and tamper-evident closure, and a serving-size accurate scoop or capsule. Most US facilities will apply FNSKU labels and FBA prep as part of the run if you sell on Amazon. Ship master cases to Amazon FC, to your 3PL, or both. Hold one master case from each batch for two years for traceability and customer service triage.
These ranges hold for a custom-blend capsule, gummy, powder, or stick-pack SKU at startup scale. Single-active SKUs (a creatine, a magnesium) push the lower end. Complex blends (sleep stacks, nootropic stacks, multi-active gummies) push the upper end. Numbers are industry-typical, not a quote.
The single biggest first-PO surprise is batch testing. 21 CFR 111 requires it. If the quote does not include it, the factory is either non-compliant or the quote is incomplete. Ask which line is missing.
Run each line against the production PO before you sign.
// Tell
The factory will run 1,000 units of your custom stack at $2.10 per unit including label and bottle.
// Fix
$2.10 per unit on a 1,000-unit custom-blend capsule run is mathematically incompatible with 21 CFR 111 batch testing, COA delivery, and a US-registered cGMP facility. Either the formula is not actually custom (it is private-label off a stock SKU), or the COA is not real. Send a sample to Eurofins. Verify.
// Tell
Reviews start landing in month three complaining the capsules taste like fish even though there is no fish in the formula.
// Fix
Cross-contamination at a non-allergen-segregated facility. Check the facility's allergen control program before you sign. Ask which actives were run in the line the week before yours. If they cannot tell you, that is the answer.
// Tell
The third-party assay came back at 64% of label claim on the hero active.
// Fix
This is why you third-party verify. Reject the batch. Most cGMP agreements have a label-claim tolerance clause — typically ±10%. Anything outside that, the factory eats the cost of the rerun. If the agreement does not have that clause, that is on the contract not the chemistry. Add it before signing.
// Tell
Wholesale retailer asked for a copy of the cGMP certificate and a Customer Manufacturing Agreement signed by an officer of the facility.
// Fix
Both of these should already be on file. The cGMP attestation is part of the Manufacturer Quality Agreement (MQA) the factory should issue when you sign. If the factory will not sign an MQA, walk.
// Tell
The Amazon listing got flagged for a structure-function claim and the entire ASIN got suppressed.
// Fix
Pre-clear claims through the DSHEA structure-function lens before printing labels or building the listing. The FDA disclaimer must appear with every structure-function claim. A supplement-specialist paralegal will redline a claim sheet for $300-$800. Cheaper than a suppressed ASIN.
We are a sourcing brokerage, not a manufacturer. We translate your formula into a one-page manufacturer brief, verify each shortlisted facility against the FDA Food Facility Registration and the NSF or NPA registries, scope batch testing and third-party assay into every quote, and review the production agreement before you sign. Flat sourcing fee per SKU. You pay the factory directly. You own the formula. We stay on the call during sample and production.
Every link below was selected because it appears in the spec flow for this buyer path. Services, industries, journal posts, and glossary entries — same content base, indexed for your stage.
If you start with a stock-formula SKU.
Custom blend, your IP. Default for hero SKUs.
Translate your thesis into a manufacturable spec.
Bottle, label, dieline, FDA disclaimer placement.
DTC fulfillment with subscription-aware pick logic.
Filtered list with cGMP status.
Full cost-line breakdown for a 1,000-unit run.
Why custom blends start at 1,000.
Shortlist methodology.
The 1994 act that governs supplements.
Good Manufacturing Practices.
Current GMP, the regulatory baseline.
Certificate of Analysis per batch.
21 CFR 111 requires it. Period.
Independent assay verification.
Independent supplement certification.
Active + dose + rationale spec.
Minimum order quantity.
Cost of goods sold.
Sets the expiry date you put on the label.
/ All citations verified against the issuing body's published page. Last verified: 2026-05-10.
Tell us format, actives, target MOQ, certifications you need, channel mix (Amazon, DTC, retail), and your timeline. We will come back inside 36 hours with three cGMP sourcing routes.